Kyowa Hakko Kirin Co., Ltd. re-affirmed earnings guidance for the year ending December 31, 2019. The company previously announced that it had concluded an agreement to transfer 95% of its shareholdings in its consolidated subsidiary Kyowa Hakko Bio Co., Ltd. to Kirin Holdings Company Limited. The company announced that although the transfer price has yet to be determined at this point in time, the consolidated earnings forecasts for the year ending December 31, 2019 remains unchanged because the impact of this transaction has been reflected in the forecasts which were announced on February 5, 2019.